Skip to content

Retrospective study of nonsteroidal anti-inflammatory drugs on the prognosis of patients under severe trauma

Key technology study of nonsteroidal anti-inflammatory drugs along with antibiotics on the prevention and treatment of war wound infection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055794
Enrollment
Unknown
Registered
2022-01-19
Start date
2022-01-31
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe trauma

Interventions

patients under severe trauma using NSAIDs:Nil

Sponsors

Daping Hospital of Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The inpatients who were in intensive care unit (ICU) because of trauma, with the age range from 16 to 75 years old; 2. The inpatients who were registered in hospital within 48 hours after trauma; 3. The score of injury severity score (ISS) was greater than or equal to 16, or the score of abbreviated injury score (AIS) was greater than or equal to 3; 4. The length of stay in ICU of hospital was longer than or equal to 5 days.

Exclusion criteria

Exclusion criteria: 1. Children, pregnant women, and the inpatients with hypersensitivity; 2. The inpatients with the following risk factors: (1) The inhabitants who lived in nursing facility (such as the elderly welfare home, sanatorium) for long time; (2) Combined with chronic respiratory system disease (such as bronchial asthma, chronic obstructive pulmonary disease (COPD), and so on); (3) Combined with chronic cardiovascular system disease (such as congenital heart disease, congestive heart failure or coronary artery disease, not including hypertension without any other related symptom of heart); (4) Combined with hematological system disease (such as chronic myelogenous leukemia (CML) / chronic lymphocytic leukemia (CLL), myelodysplastic syndrome, aplastic anemia, and so on); (5) Disorder of nervous system disease and neural development, including disability of brain, spinal cord, peripheral nerves and muscle, such as cerebral palsy (CP), epilepsy (seizure disorder), stroke, dysnoesia, hypovolutism from midrange to severe, muscular dystrophies or spinal cord injuries; (6) Poor control of chronic metabolic disease and endocrine system disease; (7) Immune function suppression, such as long-term using immunosuppressive agents, human immunodeficiency virus (HIV) infection, or immunocompromice caused by malignant tumor; (8) Infectious disease.

Design outcomes

Primary

MeasureTime frame
The incidence of sepsis after severe trauma;The mortality at 14d after severe traumatic sepsis;The mortality at 28d after severe traumatic sepsis;The incidence of acute respiratory distress syndrome (ARDS);The incidence of multiple organ failure (MODS);

Secondary

MeasureTime frame
Critical illness score;Vital sign record;Common status;The concentration of anti / pro-inflammatory factor in serum;Blood biochemical indicator;

Countries

China

Contacts

Public ContactYan Jun

Daping Hospital of Chongqing

13883092250@163.com+86 13883092250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026